IP ThinkTank is now 2 months old.  

The conversations in July & August ’07 have already been fantastic, and I really want to thank those who have added their valuable insights to the ongoing conversation:

Ajay A Menezes, Allan J Main, Ben Roxborough, David MIrchin, Guru Nataraj, Leighton Howard, Lindsaylobe, Martin Leeuwangh, Narayan,  Riz Mohammad, Shamnad Basheer, Vaibhav Vutts, and Victor Zalakos, 

Thanks so much and thank you to the many people who have newly subscribed by email or RSS over the past two months.

Here are the four posts which generated the most discussion – please feel free to add your comments:

1. Novartis’ glivec battle with India – patentability of pharmaceutical extension patents (17 comments);

2. Big Blue proposes new type of patent right – the EIP (6 comments);

3. Lifecycle Management at risk? Will Asian countries follow India’s 3(d) lead? (6 comments);

4. Patent litigation in India – uncommon and in need of reform? (6 comments)

I look forward to continuing the conversation in September and beyond.